Sonoma Pharmaceuticals (NASDAQ:SNOA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced [Yahoo! Finance]
Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf [Yahoo! Finance]
Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals [Yahoo! Finance]
Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA [Yahoo! Finance]